Overview

An Open, Single Centre, Randomised, Parallel Group Study to Investigate Three Different Immunosuppressive Regimens

Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
An open, single center, randomised study to investigate three different immunosuppressive regimens for de novo renal transplant recipients: 1. st sirolimus / EC-MPS / tacrolimus regimen - After 3 months a protocol biopsy is performed. If no rejection is detected the calcineurin inhibitor (tacrolimus) is withdrawn. 2. nd everolimus / EC-MPS / tacrolimus regimen - After 3 months a protocol biopsy is performed. If no rejection is detected the calcineurin inhibitor (tacrolimus) is withdrawn. 3. rd tacrolimus / EC-MPS / prednisone regimen - After 3 months a protocol biopsy is performed. If no rejection is detected prednisone is withdrawn.
Phase:
Phase 4
Details
Lead Sponsor:
University Hospital, Basel, Switzerland
Collaborator:
Novartis
Treatments:
Everolimus
Immunosuppressive Agents
Prednisone
Sirolimus
Tacrolimus